Nov 26, 2021 7:00am EST Can-Fite Reports Third Quarter 2021 Financial Results & Provides Clinical Update
Nov 24, 2021 7:00am EST Can-Fite CEO Dr. Pnina Fishman to be Guest Speaker at 5th Annual NASH Summit 2021
Nov 23, 2021 7:00am EST Can-Fite’s Piclidenoson Commences Clinical Study for the Treatment of Canine Osteoarthritis
Nov 01, 2021 7:00am EDT Can-Fite’s Findings on Cannabis Compound’s Inhibition of Liver Cancer are Published in HEPATOLOGY and will be Presented at the AASLD’s The Liver Meeting® 2021 Conference
Oct 26, 2021 7:00am EDT Can-Fite CEO to Present Namodenoson’s Clinical Trial Data as Expert Speaker at 5th Annual Antifibrotic Drug Development Summit
Oct 21, 2021 7:00am EDT Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal
Oct 05, 2021 7:00am EDT Can-Fite to Present at H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021
Sep 22, 2021 7:00am EDT Can-Fite CEO to Join Benzinga Medical Cannabis Panel and Deliver Company Presentation at Healthcare Small Cap Conference on September 29, 2021
